BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. World J Gastroenterol 2012; 18(22): 2813-2820 [PMID: 22719190 DOI: 10.3748/wjg.v18.i22.2813]
URL: https://www.wjgnet.com/1007-9327/full/v18/i22/2813.htm
Number Citing Articles
1
Stefano Romeo, Arun Sanyal, Luca Valenti. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver DiseaseCell Metabolism 2020; 31(1): 35 doi: 10.1016/j.cmet.2019.12.002
2
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/460190
3
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler LebererkrankungenDer Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
4
Yelena Z. Ginzburg, Karin E. Finberg. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics2021; : 445 doi: 10.1016/B978-0-12-812535-9.00012-1
5
Jessica Seeßle, Hongying Gan-Schreier, Marietta Kirchner, Wolfgang Stremmel, Walee Chamulitrat, Uta Merle. Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01282-3
6
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 133 doi: 10.1007/978-3-031-33548-8_12
7
Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra, Marcello Mancini, Luca Miele, Valerio Nobili, Gianluca Svegliati Baroni, Federico Alessandro, Stefano Ballestri, Maurizia Rossana Brunetto, Barbara Coco, Antonio Grieco, Silvia Fargion, Loreta Kondili, Fabio Nascimbeni, Anna Prinster, Dante Romagnoli, Stefano Taddei, Ester Vanni, Stefano Vella. A “systems medicine” approach to the study of non-alcoholic fatty liver diseaseDigestive and Liver Disease 2016; 48(3): 333 doi: 10.1016/j.dld.2015.10.027
8
Peter J  Meffert. Effects of the PNPLA3–SNP rs738409 on Serum Transaminase levels are modified by body mass index and alcohol consumptionBiometrics & Biostatistics International Journal 2018; 7(4) doi: 10.15406/bbij.2018.07.00227
9
James C. Barton, Christine E. McLaren, Wen-pin Chen, Grant A. Ramm, Gregory J. Anderson, Lawrie W. Powell, V. Nathan Subramaniam, Paul C. Adams, Pradyumna D. Phatak, Lyle C. Gurrin, John D. Phillips, Charles J. Parker, Mary J. Emond, Gordon D. McLaren. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y HomozygotesAnnals of Hepatology 2018; 17(5): 871 doi: 10.5604/01.3001.0012.3169
10
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studiesMedicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
11
Maria Antonella Burza, Antonio Molinaro, Maria Luisa Attilia, Claudia Rotondo, Fabio Attilia, Mauro Ceccanti, Flaminia Ferri, Federica Maldarelli, Angela Maffongelli, Adriano De Santis, Adolfo Francesco Attili, Stefano Romeo, Stefano Ginanni Corradini. PNPLA3 I148M (rs738409) genetic variant and age at onset of at‐risk alcohol consumption are independent risk factors for alcoholic cirrhosisLiver International 2014; 34(4): 514 doi: 10.1111/liv.12310
12
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2961 doi: 10.1007/978-3-319-26956-6_165
13
Luca Valenti, Serena Pelusi, Luisa Ronzoni. Comprehensive Guide to Hepatitis Advances2023; : 443 doi: 10.1016/B978-0-323-98368-6.00013-6
14
Nirupama Trehanpati, Dinesh Rawat, Hamed Hemati. Genome Analysis and Human Health2017; : 43 doi: 10.1007/978-981-10-4298-0_3
15
Monika Rau, Katharina Baur, Andreas Geier. Host Genetic Variants in the Pathogenesis of Hepatitis CViruses 2012; 4(12): 3281 doi: 10.3390/v4123281
16
George G. Schweitzer, Brian N. Finck. Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver DiseaseAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/498369
17
Sara Pelucchi, Stefania Galimberti, Federico Greni, Raffaela Rametta, Raffaella Mariani, Irene Pelloni, Domenico Girelli, Fabiana Busti, Giulia Ravasi, Maria Grazia Valsecchi, Luca Valenti, Alberto Piperno. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE‐related hemochromatosisJournal of Gastroenterology and Hepatology 2016; 31(7): 1342 doi: 10.1111/jgh.13315
18
Olivier Loréal, Thibault Cavey, François Robin, Moussa Kenawi, Pascal Guggenbuhl, Pierre Brissot. Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel AspectsPharmaceuticals 2018; 11(4): 131 doi: 10.3390/ph11040131
19
Darrell H. G. Crawford, Grant A. Ramm, Kim R. Bridle, Amanda J. Nicoll, Martin B. Delatycki, John K. Olynyk. Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the LiverHepatology International 2023; 17(3): 522 doi: 10.1007/s12072-023-10510-3
20
Cristina Maglio, Carlo Pirazzi, Arturo Pujia, Luca Valenti, Stefano Romeo. The PNPLA3 I148M variant and chronic liver disease: When a genetic mutation meets nutrientsFood Research International 2014; 63: 239 doi: 10.1016/j.foodres.2014.01.055
21
Benedetta Donati, Benedetta Maria Motta, Piero Pingitore, Marica Meroni, Alessandro Pietrelli, Anna Alisi, Salvatore Petta, Chao Xing, Paola Dongiovanni, Benedetta del Menico, Raffaela Rametta, Rosellina Margherita Mancina, Sara Badiali, Anna Ludovica Fracanzani, Antonio Craxì, Silvia Fargion, Valerio Nobili, Stefano Romeo, Luca Valenti. The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damageHepatology 2016; 63(3): 787 doi: 10.1002/hep.28370
22
Samantha G. Tilson, Carola M. Morell, An‐Sofie Lenaerts, Seung Bum Park, Zongyi Hu, Benjamin Jenkins, Albert Koulman, T. Jake Liang, Ludovic Vallier. Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem CellsHepatology 2021; 74(6): 2998 doi: 10.1002/hep.32063
23
Kalliopi Azariadis, Nikolaos K. Gatselis, Aggeliki Lyberopoulou, Pinelopi Arvaniti, Kalliopi Zachou, Stella Gabeta, George N. Dalekos. PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortalityJournal of Translational Autoimmunity 2024; 9: 100243 doi: 10.1016/j.jtauto.2024.100243
24
Amit G Singal, Hema Manjunath, Adam C Yopp, Muhammad S Beg, Jorge A Marrero, Purva Gopal, Akbar K Waljee. The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysisAmerican Journal of Gastroenterology 2014; 109(3): 325 doi: 10.1038/ajg.2013.476
25
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems BiologyHepatology 2020; 72(1): 330 doi: 10.1002/hep.31229
26
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical reviewWorld Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
27
Eric Trépo, Luca Valenti. Update on NAFLD genetics: From new variants to the clinicJournal of Hepatology 2020; 72(6): 1196 doi: 10.1016/j.jhep.2020.02.020
28
Albert Friedrich Stättermayer, Stefan Traussnigg, Hans-Peter Dienes, Elmar Aigner, Rudolf Stauber, Karoline Lackner, Harald Hofer, Judith Stift, Friedrich Wrba, Andreas Stadlmayr, Christian Datz, Michael Strasser, Andreas Maieron, Michael Trauner, Peter Ferenci. Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutationsJournal of Hepatology 2015; 63(1): 156 doi: 10.1016/j.jhep.2015.01.034
29
Luca Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo. PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare diseaseDigestive and Liver Disease 2013; 45(8): 619 doi: 10.1016/j.dld.2012.12.006
30
Antonello Pietrangelo. Zakim and Boyer's Hepatology2018; : 941 doi: 10.1016/B978-0-323-37591-7.00060-4
31
Paola Dongiovanni, Luca Valenti. Genetics of nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1026 doi: 10.1016/j.metabol.2015.08.018
32
Jian-Hua Shen, Yi-Ling Li, Dan Li, Ning-Ning Wang, Lei Jing, Yu-Hong Huang. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysisJournal of Lipid Research 2015; 56(1): 167 doi: 10.1194/jlr.M048777
33
Elena Corradini, Elena Buzzetti, Antonello Pietrangelo. Genetic iron overload disordersMolecular Aspects of Medicine 2020; 75: 100896 doi: 10.1016/j.mam.2020.100896
34
Pierre Brissot, Thibault Cavey, Martine Ropert, François Gaboriau, Olivier Loréal. Hemochromatosis: a model of metal-related human toxicosisEnvironmental Science and Pollution Research 2018; 25(3): 2007 doi: 10.1007/s11356-016-7576-2
35
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factorsWorld Journal of Gastroenterology 2014; 20(36): 12945-12955 doi: 10.3748/wjg.v20.i36.12945
36
Stephan Buch, Aneesh Sharma, Eleanor Ryan, Christian Datz, William J. H. Griffiths, Michael Way, Thomas W. M. Buckley, John D. Ryan, Stephen Stewart, Callum Wright, Paola Dongiovanni, Anna Fracanzani, Jochen Zwerina, Uta Merle, Karl Heinz Weiss, Elmar Aigner, Elisabeth Krones, Christian Dejaco, Janett Fischer, Thomas Berg, Luca Valenti, Heinz Zoller, Andrew McQuillin, Jochen Hampe, Felix Stickel, Marsha Y. Morgan. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisAlimentary Pharmacology & Therapeutics 2021; 53(7): 830 doi: 10.1111/apt.16252
37
Antonello Pietrangelo. Iron and the liverLiver International 2016; 36(S1): 116 doi: 10.1111/liv.13020
38
Eric Trépo, Stefano Romeo, Jessica Zucman-Rossi, Pierre Nahon. PNPLA3 gene in liver diseasesJournal of Hepatology 2016; 65(2): 399 doi: 10.1016/j.jhep.2016.03.011
39
O. V. Smirnova, O. L. Moskalenko, E. V. Kasparov, I. E. Kasparova. Genetic predictors and pathophysiological features of non-alcoholic fat liver diseaseMeditsinskiy sovet = Medical Council 2021; (15): 78 doi: 10.21518/2079-701X-2021-15-78-87
40
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav A. Hubáček, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa, Rudolf Poledne. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based studyDigestive and Liver Disease 2018; 50(5): 490 doi: 10.1016/j.dld.2017.12.030
41
Antonello Pietrangelo. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since HepcidinGastroenterology 2015; 149(5): 1240 doi: 10.1053/j.gastro.2015.06.045
42
Luca Valenti, Anna Ludovica Fracanzani, Raffaela Rametta, Mirella Fraquelli, Giulia Soverini, Serena Pelusi, Paola Dongiovanni, Dario Conte, Silvia Fargion. Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosisJournal of Hepatology 2012; 57(6): 1319 doi: 10.1016/j.jhep.2012.07.041
43
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_165-1
44
John K. Olynyk, Richard Grainger, Helen Currie, Louise E. Ramm, Grant A. Ramm. The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosisScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35028-4